9 minute read
Nov. 1, 2023

STX-721: EGFR Ex20ins Inhibitor with Potential Best-in-Class Selectivity.


oral covalent EGFR ex20ins mutant-selective inhibitor Ph. I for NSCLC with EGFR ex20ins mutations opt. from screen of TKI's for EGFR ex20ins selectivity First Disclosures, ACS Fall 2023 Scorpion Therapeutics, Boston, MA


Molecules of the Month